Today: 29 April 2026
Browse Category

NASDAQ:PSTG 1 December 2025 - 12 January 2026

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage shares rose 7.9% to $72.29 on Monday, outpacing the broader market. A Friday filing showed founder John Colgrove transferred 200,000 shares as gifts between family trusts. Investors are watching Tuesday’s U.S. CPI report and Pure’s presentation at the Needham Growth Conference on Thursday. Peer stocks, including NetApp and Western Digital, also advanced.
Seagate Technology (STX) Stock After Hours Today, Dec. 24, 2025: What Happened After the Bell and What to Watch Before Markets Reopen

Seagate Technology (STX) Stock After Hours Today, Dec. 24, 2025: What Happened After the Bell and What to Watch Before Markets Reopen

Seagate shares closed up 1.14% at $285.27 in a holiday-shortened session Wednesday, then slipped 0.25% to $284.56 after hours. Volume was light at 1.5 million shares, well below the 50-day average. The move came as U.S. indexes hit record highs. Seagate remains 7.66% below its December peak of $308.93.
Nutanix Stock (NTNX) Today: Sovereign Cloud Push, Pure Storage Partnership, and Analyst Forecasts After the Selloff

Nutanix Stock (NTNX) Today: Sovereign Cloud Push, Pure Storage Partnership, and Analyst Forecasts After the Selloff

Nutanix stock rebounded to around $49 on Dec. 15 after a 30% slide since mid-November. The move followed the company’s announcement of expanded “sovereign cloud” capabilities, including new security and on-premises management features. Monday’s gains marked a 3–4% rise during the session. Investors remain focused on whether the business outlook has changed.
US Stock Market Today, December 1, 2025: Futures Fall as Fed Cut Bets Clash With Oil Spike and Bitcoin Slump

US Stock Market Today, December 1, 2025: Futures Fall as Fed Cut Bets Clash With Oil Spike and Bitcoin Slump

U.S. stock futures fell Monday, with Dow, S&P 500, and Nasdaq contracts down 0.4% to 0.8% after last week’s strong rally. Bitcoin dropped sharply, oil prices climbed, and traders increased bets on a Federal Reserve rate cut next week. Gold hit a six-week high. China’s factory and services data slipped into contraction, adding to global growth concerns.

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop